Title
Medical Surveillance Program for NRC - Clinical Trial Material Facility - CTMF
Reference number
cb-705-3221879
Solicitation number
26-58074
Publication date
2026-07-15
Tender closing date
2026-08-21T14:00:00
Expected contract start date
2026-09-15
Expected contract end date
2028-09-29
Unspsc
*25101937
*85110000
Unspsc description
*Medical examination and treatment bus
*Disease prevention and control
Notice type
Request for Proposal
Procurement method
Competitive - Open bidding
Selection criteria
Lowest Price
Trade agreements
*Canada-Honduras Free Trade Agreement
*Canada-Colombia Free Trade Agreement
*Canada-Chile Free Trade Agreement (CCFTA)
*Canada-Panama Free Trade Agreement
*Canada-Korea Free Trade Agreement (CKFTA)
Regions of opportunity
*Canada
Regions of delivery
*Canada
Contracting entity name
National Research Council of Canada (NRC)
Contracting entity address line
6100 Royalmount Ave
Contracting entity address city
Montreal
Contracting entity address province
Quebec
Contracting entity address postal code
H4P 2R2
Contracting entity address country
Canada
Contact info name
Cindy Romain
Contact info email
cindy.romain@nrc-cnrc.gc.ca
Contact info phone
(613) 299-2748
Contact info address line
6100 Royalmount Ave
Contact info city
Montreal
Contact info postalcode
H4P 2R2
Contact info country
Canada
Attachment
https://canadabuys.canada.ca/sites/default/files/webform/tender_notice/100643/english_rfp_26-58074_medical_surveillance_ctmf_14_july_annex_final_posted.pdf
Tender description
To perform timely and ongoing health evaluations, as required, for identified staff from the
NRC-Clinical Trial Material Facility (NRC-CTMF) in accordance with the NRC-CTMF Medical
Surveillance Program.
The NRC has established a new Good Manufacturing Practices (GMP)-compliant Clinical
Trial Material Facility (CTMF) at its Royalmount Avenue site in Montréal. This facility will
produce vaccines and other biologic materials for clinical trials on behalf of NRC partners
and collaborators, supporting Canada’s biomanufacturing capacity and pandemic
preparedness.
Accordingly, the CTMF Quality System requires the implementation of a Medical Surveillance
Program, as outlined in a Standard Operating Procedure (SOP), to ensure product safety. This
program ensures that all personnel accessing the facility meet the minimum health
requirements aligned with their operational duties.
The procedure covers the verification, documentation, and confirmation of the personnel
fitness to access production areas and/or perform assigned tasks through medical
assessments conducted by designated healthcare professionals at an Occupational Health
Center (OHC). It also includes additional health evaluations following any reported illness or
injury.
